Back

dr. R.S. (Rachel) van Leeuwaarde

dr. R.S. (Rachel) van Leeuwaarde

Research Staff Other

Show full profile

Research Output (52)

A Multinational Pilot Study on Patients’ Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ‐C30 and EORTC QLQ‐GINET21 Questionnaires

van Leeuwaarde Rachel S., González‐clavijo Angélica M., Pracht Marc, Emelianova Galina, Cheung Winson Y., Thirlwell Christina, Öberg Kjell, Spada Francesca 25 Feb 2022, In: Journal of Clinical medicine. 11 , p. 1-10

Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?

Naber Myrthe R, Ahmad Saya, Verrijn Stuart Annemarie A, Giles Rachel H, Valk Gerlof D, van Leeuwaarde Rachel S 1 Feb 2022, In: JOURNAL OF THE ENDOCRINE SOCIETY. 6 , p. 1-6

Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults:incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center

Piek Marceline W., de Vries Lisa H., Donswijk Maarten L., de Keizer Bart, de Boer Jan Paul, Lodewijk Lutske, van Leeuwaarde Rachel S., Vriens Menno R., Hartemink Koen J., van der Ploeg Iris M.C. 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49 , p. 2392-2400 9 p.

Reply to "von Hippel-Lindau disease integrated care pathway:Centralizing, expanding specialists' theatre, and measuring improvement"

van Leeuwaarde Rachel S., Wolters Wendy P.G., Dreijerink Koen M.A., Giles Rachel H. 2022, In: Cancer. 128 , p. 4029 1 p.

[18F]mFBG PET/CT imaging outperforms MRI and [68 Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma.

Suurd Diederik P.D., Poot Alex J., van Leeuwaarde Rachel S., Windhorst Albert D., Vriens Menno R., de Keizer Bart 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 50 , p. 1538-1540 3 p.

[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.

de Koster Elizabeth J., van Engen-van Grunsven Adriana C.H., Bussink Johan, Frielink Cathelijne, de Geus-Oei Lioe Fee, Kusters Benno, Peters Hans, Oyen Wim J.G., Vriens Dennis, Netea-Maier Romana T., Smit Jan W.A., de Wilt Johannes H.W., Booij Jan, Fliers Eric, Klooker Tamira K., van Dam Eveline W.C.M., Dreijerink Koen M.A., Raijmakers Pieter G.H.M., Kam Boen L.R., Peeters Robin P., Verzijlbergen John F., van Aken Maarten O., Jager Piet L., Mijnhout G. Sophie, van den Hout Wilbert B., Arias Alberto M.Pereira, Morreau Johannes, Snel Marieke, Dijkhorst-Oei Lioe Ting, de Klerk John M.H., Havekes Bas, Mitea D. Cristina, Vöö Stefan, Brouwer Catharine B., van Dam Pieter S., Sivro Ferida, te Beek Erik T., Jebbink Max C.W., Bleumink Gysele S., Schelfhout Vanessa J.R., Keijsers Ruth G.M., Wakelkamp Iris M.M.J., Brouwers Adrienne H., Links Thera P., de Keizer Bart, van Leeuwaarde Rachel S., Bonenkamp Johannes J., Donders A. Rogier T., Fütterer Jurgen J., 2022, In: Molecular Imaging and Biology. 25 , p. 483-494 12 p.

Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study

Ebbers Sander C., Heimgartner Muriel, Barentsz Maarten W., van Leeuwaarde Rachel S., van Treijen Mark J. C., Lam Marnix M. E. G., Braat Arthur J. A. T. 9 Dec 2021, In: European Journal of Hybrid Imaging. 5 , p. 1-11

Retrospective analyses of 18FDG-PET/CT thyroid incidentaloma in adults:incidence, treatment and outcome in a tertiary cancer referral center

Piek Marceline W, de Boer Jan Paul, Vriens Menno R, van Leeuwaarde Rachel S, Stokkel Marcel, Hartemink Koen J, van Duijnhoven Frederieke, Kessels Rob, van der Ploeg Iris M C 3 Sep 2021, In: Thyroid. 31 , p. 1715-1722 8 p.

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients:results from the DutchMEN Study Group

Klein Haneveld Mirthe J, van Treijen Mark J C, Pieterman Carolina R C, Dekkers Olaf M, van de Ven Annenienke, de Herder Wouter W, Zandee Wouter T, Drent Madeleine L, Bisschop Peter H, Havekes Bas, Vriens Menno R, Verrijn Stuart Annemarie A, Valk Gerlof D, van Leeuwaarde Rachel S 1 Aug 2021, In: The Journal of clinical endocrinology and metabolism. 106 , p. 3515-3525 11 p.

A blood-based polyamine signature associated with MEN1 duodenopancreatic neuroendocrine tumor progression

Fahrmann Johannes F, Wasylishen Amanda R, Pieterman Carolina R C, Irajizad Ehsan, Vykoukal Jody, Murage Eunice, Wu Ranran, Dennison Jennifer B, Krishna Hansini, Peterson Christine B, Lozano Guillermina, Zhao Hua, Do Kim-Anh, Halperin Daniel M, Agarwal Sunita K, Blau Jenny E, Del Rivero Jaydira, Nilubol Naris, Walter Mary F, Welch James M, Weinstein Lee S, Vriens Menno R, van Leeuwaarde Rachel S, van Treijen Mark J C, Valk Gerlof D, Perrier Nancy D, Hanash Samir M 28 Jul 2021, In: The Journal of clinical endocrinology and metabolism. 106 , p. E4969-E4980

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not